31-Mar-24 | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
China & japan | 170.90 | 36% | 154.10 | 35% | 142.90 | 39% | 116.40 | 37% | 108.20 | 34% |
Rest of Asia | 50.60 | 11% | 47.10 | 11% | 45.70 | 12% | 33.80 | 11% | 28.40 | 9% |
Rest of Europe | 50.30 | 11% | 43.40 | 10% | 40.70 | 11% | 39.90 | 13% | 44.80 | 14% |
Rest of World | 21.10 | 4% | 17.40 | 4% | 9.80 | 3% | 9.00 | 3% | 12.40 | 4% |
UK | 30.40 | 6% | 29.40 | 7% | 20.20 | 5% | 14.50 | 5% | 13.40 | 4% |
USA & germany | 147.10 | 31% | 153.30 | 34% | 108.00 | 29% | 104.90 | 33% | 110.20 | 35% |
Total | 470.40 | 100% | 444.70 | 100% | 367.30 | 100% | 318.50 | 100% | 317.40 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 71.30 | 100% | 73.50 | 100% | 47.60 | 100% | 52.20 | 100% | 38.80 | 100% |
Total | 71.30 | 100% | 73.50 | 100% | 47.60 | 100% | 52.20 | 100% | 38.80 | 100% |
31-Mar-24 | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Materials & Characterisation | 252.20 | 54% | 234.50 | 53% | 185.50 | 51% | 148.60 | 47% | 137.60 | 43% |
Research & Discovery | 142.10 | 30% | 139.40 | 31% | 120.30 | 33% | 113.40 | 36% | 126.00 | 40% |
Service & Healthcare | 76.10 | 16% | 70.80 | 16% | 61.50 | 17% | 56.50 | 18% | 53.80 | 17% |
Total | 470.40 | 100% | 444.70 | 100% | 367.30 | 100% | 318.50 | 100% | 317.40 | 100% |
Profit Before Tax | ||||||||||
Materials & Characterisation | n/a | n/a | n/a | n/a | n/a | n/a | 16.60 | 32% | n/a | n/a |
Research & Discovery | n/a | n/a | n/a | n/a | n/a | n/a | 13.10 | 28% | n/a | n/a |
Service & Healthcare | n/a | n/a | n/a | n/a | n/a | n/a | 16.90 | 36% | n/a | n/a |
Unanalysed | 71.30 | n/a | 73.50 | n/a | 47.60 | n/a | 5.60 | n/a | 38.80 | n/a |
Total | 71.30 | n/a | 73.50 | n/a | 47.60 | n/a | 52.20 | 100% | 38.80 | n/a |
You are here: research